Company Filing History:
Years Active: 1999-2001
Title: Joon Seo Park: Innovator in Cholesterol Biosynthesis Inhibitors
Introduction
Joon Seo Park is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of cholesterol biosynthesis inhibitors, holding a total of 6 patents. His work focuses on developing compounds that can effectively treat conditions related to cholesterol and lipid levels in the body.
Latest Patents
Among his latest patents, Park has developed a cholesterol biosynthesis inhibitor that specifically targets sterol 14-reductase, an enzyme involved in the distal pathway of cholesterol biosynthesis. This invention includes a compound of formula (1) and the use of an extract or the compound for treating hypercholesterolaemia or hyperlipidaemia. The inhibitor is derived from an extract obtained through solvent extraction or from organic layers partitioned from the extract. The active ingredients include 7,8,13,13α-tetrahydrocoridaline or its derivatives, which effectively inhibit the enzyme responsible for cholesterol biosynthesis.
Another notable patent by Park involves 13,13A-Didehydroberbine derivatives, which also serve as cholesterol biosynthesis inhibitors. This invention similarly targets sterol 14-reductase and utilizes extracts from Corydalis Turtschaninowii Besser. The active ingredients in this patent are also 7,8,13,13α-tetrahydrocoridaline or its derivatives, showcasing Park's consistent focus on innovative solutions for cholesterol management.
Career Highlights
Throughout his career, Joon Seo Park has worked with notable companies such as Hanwha Corporation and Hanwha Chemical Corporation. His experience in these organizations has contributed to his expertise in developing pharmaceutical innovations.
Collaborations
Park has collaborated with several professionals in his field, including Jung Ho Kim and Tae Neung Jhong. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Joon Seo Park is a distinguished inventor whose work in cholesterol biosynthesis inhibitors has the potential to impact the treatment of hypercholesterolaemia and hyperlipidaemia significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.